Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BRCA1 is a cell cycle-regulated nuclear phosphoprotein

H Ruffner1, I M Verma

  • 1Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 8, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of therapeutic targets for glioblastoma by network analysis.

Oncogene·2015
Same author

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.

Oncogene·2011
Same author

NF-kappaB and the regulation of hematopoiesis.

Cell death and differentiation·2006
Same author

Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Annals of the rheumatic diseases·2004
Same author

Opportunities for the use of lentiviral vectors in human gene therapy.

Current topics in microbiology and immunology·2002
Same author

Gene therapy and jurisprudence.

Molecular therapy : the journal of the American Society of Gene Therapy·2001

Researchers characterized the BRCA1 gene product, a nuclear phosphoprotein crucial in breast cancer cells. Its phosphorylation levels change significantly during the cell cycle, suggesting a role in cell cycle progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The BRCA1 gene is a critical tumor suppressor involved in DNA repair.
  • Understanding the BRCA1 protein's function and regulation is vital for breast cancer research.

Purpose of the Study:

  • To characterize the BRCA1 gene product (protein).
  • To investigate the expression patterns and cell cycle-dependent modifications of BRCA1.

Main Methods:

  • Utilized four polyclonal antibodies targeting different regions of the BRCA1 protein.
  • Analyzed BRCA1 protein expression in normal and neoplastic breast cancer cells.
  • Investigated BRCA1 phosphorylation status across different phases of the cell cycle.

Main Results:

Related Experiment Videos

  • Successfully identified and characterized an approximately 220-kDa BRCA1 protein.
  • Demonstrated predominant nuclear localization of BRCA1 in both normal and cancerous breast cells.
  • Revealed BRCA1 as a serine phosphoprotein exhibiting hyperphosphorylation in late G1 and S phases and transient dephosphorylation after M phase.

Conclusions:

  • BRCA1 is a nuclear phosphoprotein.
  • BRCA1 undergoes significant quantitative and qualitative changes in its phosphorylation state during cell cycle progression.
  • These cell cycle-dependent alterations suggest a role for BRCA1 in regulating cell cycle progression.